Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public Health Research Institute
May 05, 2020 09:30 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has executed...
CENTOGENElogo.jpg
CENTOGENE Announces Global Expansion of COVID-19 Testing
May 05, 2020 09:30 ET | Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN,, May 05, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical...
NSF Awards $200K Gra
NSF Awards $200K Grant to Clarkson Professors Studying Transmission of SARS-CoV-2 Virus
April 28, 2020 16:34 ET | Clarkson University
Potsdam, NY, April 28, 2020 (GLOBE NEWSWIRE) -- Recent scientific and media reports have highlighted the risk of airborne transmission of the SARS-CoV-2 virus, which causes COVID-19. While it is...
Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
April 27, 2020 09:30 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has been...
jpt1.jpg
JPT Launches Broad Spectrum of COVID-19 Peptide Tools for Immune Monitoring, Vaccine & Diagnostics Development
April 22, 2020 07:00 ET | JPT Peptide Technologies
BERLIN, April 22, 2020 (GLOBE NEWSWIRE) -- JPT Peptide Technologies (JPT) announces the launch of ready-to-use peptide tools to study and profile the immune response towards SARS-CoV-2 infection....
Picture 1
Screening of 11,552 Compounds Identifies Innovation Pharmaceuticals’ Brilacidin as One of the Most Promising Potential Inhibitors of the Novel Coronavirus COVID-19
April 20, 2020 09:00 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 20, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that based on molecular...
7 Hills Logo.png
7 Hills Pharma Announces Coronavirus Vaccine Program Targeting At-Risk Elderly
April 15, 2020 08:00 ET | 7 Hills Pharma
HOUSTON, April 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases,...
7 Hills Logo.png
7 Hills Pharma Announces FDA Clearance of Investigational New Drug Application for 7HP349, a First-in-Class Immune Stimulant 
April 14, 2020 08:00 ET | 7 Hills Pharma
HOUSTON, April 14, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
Pacific Biosciences logo
Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
April 08, 2020 07:30 ET | Pacific Biosciences of California, Inc.
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2...
Innovation Pharmaceuticals in Discussions to Advance Brilacidin into Human Trials Against COVID-19
April 06, 2020 07:30 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today the Company is engaged in...